|
125
|
378
|
4cg8A |
Human choline kinase a1 in complex with compound 14 |
|
88
|
280
|
4c4fA |
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 |
|
78
|
279
|
4c4iA |
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 |
|
74
|
279
|
4c4jA |
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 |
|
89
|
271
|
4c2vA |
Aurora b kinase in complex with the specific inhibitor barasertib |
|
95
|
314
|
4ckiA |
Crystal structure of oncogenic ret tyrosine kinase m918t bound to adenosine |
|
83
|
273
|
4bznA |
Crystal structure of pim1 in complex with a pyrrolo(1,2-a)pyrazinone inhibitor |
|
87
|
265
|
4cegA |
Crystal structure of aurora a 122-403 c290a, c393a bound to adp |
|
126
|
378
|
4br3A |
Determination of potential scaffolds for human choline kinase alpha 1 by chemical deconvolution studies |
|
89
|
287
|
4c61A |
Inhibitors of jak2 kinase domain |
|
70
|
307
|
4c59A |
Structure of gak kinase in complex with nanobody (nbgak_4) |
|
96
|
308
|
4cmuA |
Structure of the human anaplastic lymphoma kinase in complex with the inhibitor (10r)-7-amino-12-fluoro-1,3,10,16-tetramethyl-16,17-dihydro- 1h-8,4-(metheno)pyrazolo(4,3-h)(2,5,11)benzoxadiazacyclotetradecin-15(10h)-one |
|
108
|
338
|
4c33A |
Pka-s6k1 chimera apo |
|
96
|
309
|
4ccuA |
Structure of the human anaplastic lymphoma kinase in complex with 2-(5-(6-amino-5-((r)-1-(5-fluoro-2-(2h-1,2,3-triazol-2-yl)phenyl)ethoxy) pyridin-3-yl)-4-methylthiazol-2-yl)propan-2-ol |
|
71
|
263
|
4byjA |
Aurora a kinase bound to a highly selective imidazopyridine inhibitor |
|
89
|
287
|
4c62A |
Inhibitors of jak2 kinase domain |
|
82
|
273
|
4bzoA |
Crystal structure of pim1 in complex with a pyrrolo-pyrazinone inhibitor |
|
87
|
302
|
4cfuA |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
81
|
272
|
4brxA |
Focal adhesion kinase catalytic domain in complex with a diarylamino- 1,3,5-triazine inhibitor |
|
75
|
307
|
4c58A |
Structure of gak kinase in complex with nanobody (nbgak_4) |
|
107
|
340
|
4c35A |
Pka-s6k1 chimera with compound 1 (nu1085) bound |
|
89
|
269
|
4c2wA |
Crystal structure of aurora b in complex with amp-pnp |
|
96
|
309
|
4cmoA |
Structure of the human anaplastic lymphoma kinase in complex with the inhibitor 2-((1r)-1-((3-amino-6-(2-methoxypyridin-3-yl)pyrazin-2-yl) oxy)ethyl)-4-fluoro-n-methylbenzamide |
|
83
|
261
|
4c3fA |
Structure of lck in complex with a compound discovered by virtual fragment linking |
|
98
|
308
|
4cliA |
Structure of the human anaplastic lymphoma kinase in complex with pf- 06463922 ((10r)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16, 17-tetrahydro-2h-8,4-(metheno)pyrazolo(4,3-h)(2,5,11) benzoxadiazacyclotetradecine-3-carbonitrile). |
|
82
|
298
|
4bzdA |
Structure of cdk2 in complex with a benzimidazopyrimidine |
|
87
|
300
|
4cfnA |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
96
|
314
|
4bkjA |
Crystal structure of the human ddr1 kinase domain in complex with imatinib |
|
91
|
288
|
4bbfA |
Aminoalkylpyrimidine inhibitor complexes with jak2 |
|
83
|
288
|
4bbeA |
Aminoalkylpyrimidine inhibitor complexes with jak2 |
|
87
|
299
|
4bcmA |
Structure of cdk2 in complex with cyclin a and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
|
100
|
316
|
4bbmA |
Crystal structure of the human cdkl2 kinase domain with bound tcs 2312 |
|
82
|
263
|
4bn1A |
Crystal structure of v174m mutant of aurora-a kinase |
|
88
|
299
|
4bcoA |
Structure of cdk2 in complex with cyclin a and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
|
82
|
279
|
4bi1A |
Scaffold focused virtual screening: prospective application to the discovery of ttk inhibitor |
|
96
|
291
|
4aqcA |
Triazolopyridine-based inhibitor of janus kinase 2 |
|
79
|
283
|
4bb4A |
Ephb4 kinase domain inhibitor complex |
|
97
|
299
|
4at4A |
Crystal structure of trkb kinase domain in complex with ex429 |
|
74
|
265
|
4b8lA |
Aurora b kinase p353g mutant |
|
76
|
298
|
4bcqA |
Structure of cdk2 in complex with cyclin a and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
|
99
|
299
|
4b4lA |
Crystal structure of an ard dap-kinase 1 mutant |
|
85
|
303
|
4bdkA |
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (chk2) |
|
18
|
106
|
4bjjA |
Sfc1-sfc7 dimerization module |
|
87
|
321
|
4bcgA |
Structure of cdk9 in complex with cyclin t and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
|
78
|
279
|
4bi2A |
Scaffold focused virtual screening: prospective application to the discovery of ttk inhibitor |
|
102
|
312
|
4asdA |
Crystal structure of vegfr2 (juxtamembrane and kinase domains) in complex with sorafenib (bay 43-9006) |
|
99
|
303
|
4b9dA |
Crystal structure of human nima-related kinase 1 (nek1) with inhibitor. |
|
82
|
271
|
4bieA |
Crystal structures of ask1-inhibitor complexes |
|
80
|
273
|
4as0A |
Cyclometalated phthalimides as protein kinase inhibitors |
|
92
|
281
|
4b6lA |
Discovery of oral polo-like kinase (plk) inhibitors with enhanced selectivity profile using residue targeted drug design |
